Search Results - "Haibo, Mou"

Refine Results
  1. 1

    CircRNA_100395 Carried by Exosomes From Adipose-Derived Mesenchymal Stem Cells Inhibits the Malignant Transformation of Non-Small Cell Lung Carcinoma Through the miR-141-3p-LATS2 Axis by Zhang, Chong, Cao, Jinlin, Lv, Wang, Mou, Haibo

    “…The specific purpose of this study is to investigate the impact exosomes from adipose-derived mesenchymal stem cell (AMSC) has on non-small cell lung carcinoma…”
    Get full text
    Journal Article
  2. 2

    Case report: A case of complete clinical response in a patient experiencing high microsatellite instability unresectable colon cancer being treated with a PD-L1 inhibitor after interstitial pneumonia by Wang, Luo, Mou, Haibo, Hou, Xuehua, Liao, Qin

    Published in Frontiers in oncology (14-03-2023)
    “…Immune checkpoint inhibitors (ICI) have dramatically transformed the treatment landscape for metastatic colorectal cancer (mCRC) with deficient DNA mismatch…”
    Get full text
    Journal Article
  3. 3

    Prognostic significance of COX-2 immunohistochemical expression in colorectal cancer: a meta-analysis of the literature by Peng, Ling, Zhou, Yun, Wang, Yina, Mou, Haibo, Zhao, Qiong

    Published in PloS one (20-03-2013)
    “…Cyclooxygenase-2 (COX-2) is believed to be an important enzyme in the pathogenesis of colorectal cancer (CRC). Correlations between the expression of COX-2…”
    Get full text
    Journal Article
  4. 4

    Successful response to the combination of immunotherapy and chemotherapy in cholangiocarcinoma with high tumour mutational burden and PD-L1 expression: a case report by Mou, Haibo, Yu, Lanfang, Liao, Qin, Hou, Xuehua, Wu, Yinfang, Cui, Qiang, Yan, Na, Ma, Ruobing, Wang, Lingjian, Yao, Ming, Wang, Kai

    Published in BMC cancer (12-11-2018)
    “…Cholangiocarcinoma, or bile duct cancer, is a gastrointestinal cancer with limited therapeutic options and a poor outcome. Studies have revealed that some…”
    Get full text
    Journal Article
  5. 5

    Performance Analysis of a Single Light Source Bidirectional Visible Light Communication Reverse Reflection Link by Zhang, Ying, Ren, Jiawei, Li, Kexin, Mou, Haibo

    Published in Photonics (01-01-2024)
    “…Visible light communication has the advantages of large bandwidth, high security, and no RF interference, among which LED light sources are an important light…”
    Get full text
    Journal Article
  6. 6

    Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy by Tian, Lin, Lei, Anhua, Tan, Tianyu, Zhu, Mengmeng, Zhang, Li, Mou, Haibo, Zhang, Jin

    Published in Kidney diseases (01-01-2022)
    “…Abstract Background: Cells of the immune system can inhibit tumor growth and progression; however, immune cells can also promote tumor cell growth, survival,…”
    Get full text
    Journal Article
  7. 7

    Case report: Long-term clinical benefit of pyrotinib therapy following trastuzumab resistance in HER2 -amplification recurrent mucinous ovarian carcinoma by Fang, Xiangming, Mou, Haibo, Ying, Xinxin, Hou, Xuehua, Wang, Luo, Wu, Ying, Yan, Naimeng, Guo, Lijie, Liao, Qin

    Published in Frontiers in oncology (22-12-2022)
    “…Advanced or recurrent mucinous carcinoma of the ovary minimally responds to current cytotoxic treatments and has a poor prognosis. Despite multimodal treatment…”
    Get full text
    Journal Article
  8. 8

    P- and S-wave angle-domain common-image gathers (ADCIGs) based on elastic-wave reverse-time migration by Bingshou, He, Haibo, Mou, Nan, Hu

    Published in Geological journal (Chichester, England) (01-08-2016)
    “…Elastic‐wave reverse‐time migration is an important imaging strategy because of its ability to image complex geologic structures and to efficiently extract…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Complete remission in a patient with advanced renal pelvis carcinoma with lung metastasis treated with durvalumab immunotherapy: a case report by Wu, Yingfang, Mou, Haibo

    Published in Annals of palliative medicine (01-07-2020)
    “…For early-stage upper urothelial carcinoma, total nephroureterectomy combined with bladder sleeve resection is the standard treatment. However, for patients…”
    Get full text
    Journal Article
  12. 12

    Clinical characteristics, risk factors, and outcomes after adjuvant radiotherapy for patients with thymoma in the United States: analysis of the Surveillance, Epidemiology, and End Results (SEER) Registry (1988-2013) by Mou, Haibo, Liao, Qin, Hou, Xuehua, Chen, Te, Zhu, Yuping

    Published in International journal of radiation biology (02-04-2018)
    “…Purpose: The surgery with adjuvant radiation for the treatment of thymoma is still debated. The aim of this study was to examine the efficacy of postoperative…”
    Get full text
    Journal Article
  13. 13

    Phase Ib study of the oral PI3Kδ inhibitor linperlisib in patients with advanced solid tumors by Li, Jin, Xue, Junli, Liu, Tianshu, Feng, Yi, Xu, Nong, Huang, Jianjin, Yin, Yongmei, Zhang, Jun, Mou, Haibo, Shentu, Jiangzhong, Bao, Hanying, Xu, Zusheng, Xu, Zuhong

    Published in International journal of clinical oncology (13-11-2024)
    “…Abstract Background Patients with advanced solid tumors have a suboptimal prognosis. This study investigated the safety and feasibility of linperlisib, a…”
    Get full text
    Journal Article
  14. 14

    A phase Ib study of the PI3K δ inhibitor linperlisib in patients with advanced solid tumors by Li, Jin, Xu, Nong, Liu, Tianshu, Huang, Jianjin, Yin, Yongmei, Mou, Haibo, Zhang, Jun, Wu, Lihua, Liu, Zong liang, Bao, Hanying, Xu, Zusheng

    Published in Journal of clinical oncology (20-05-2021)
    “…Abstract only 3099 Background: Phosphatidylinositol-3 kinase (PI3K) pathways are important elements of tumor survival and progression, and PIK3C genes are…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Characterization of tumor mutation burden, PD-L1 and hepatitis B virus in Chinese hepatocellular carcinoma patients by Xu, Junjie, Liang, Xiao, Liu, Lingxiang, Mou, Haibo, Wan, Zhe, Jiang, Shi, Yang, Zhe, Zeng, Daobing, Chen, Xiaoqian, Shi, Junping, Yao, Ming, Chen, Zhonghai, Wang, Kai

    Published in Journal of clinical oncology (20-05-2019)
    “…Abstract only e15666 Background: Hepatocellular carcinoma (HCC) has a high mortality rate and is the fourth most common cancer in China. Immunotherapy of…”
    Get full text
    Journal Article
  19. 19

    Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways by Mou, Haibo, Zheng, Yi, Zhao, Peng, Bao, Hanying, Fang, Weijia, Xu, Nong

    Published in Toxicology in vitro (01-08-2011)
    “…► Celastrol inhibited proliferation and induced apoptosis in human NSCLC A549 cells. ► Celastrol induced apoptosis was through activation of mitochondria- and…”
    Get full text
    Journal Article
  20. 20

    Mutational landscape of AKT1/2/3 in Chinese patients with solid tumors by Kong, Hui, Fang, Weijia, Mou, Haibo, Chen, Feng Xiao, Liu, Lingxiang, Wei, Jia, Cui, Shiyun, Wei, Yongzhong, Li, Juming, Du, Juan, Ling, Qi, Tang, Xiaofeng, Qian, Yigang, Yu, Songfeng, Xue, Liang, Wang, Ting, Xiao, Min, Pan, Qiuyue, Zhang, Shiyue, Zhang, Lin

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only e15566 Background: As a central component of PI3K/AKT pathway, AKT serves as an attractive target of anti-cancer strategy with various AKT…”
    Get full text
    Journal Article